Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)

Oncogene

Volumn 24, Issue 8, 2005, Pages 1412-1422

  Bren Mattison, Yvette ^a   Van Putten, Vicki ^a   Chan, Daniel ^a   Winn, Robert ^a   Geraci, Mark W ^a   Nemenoff, Raphael A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Differentiation; Metastasis; Non small cell lung cancer; PPAR ; Tumorigenesis

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM METASTASIS; ORGAN CULTURE TECHNIQUES; PHENOTYPE; PPAR GAMMA; RATS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 14844316288     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208333     Document Type: Article

References (49)

1. Adams M, Reginato MJ, Shao D, Lazar MA and Chatterjee VK. (1997). J. Biol. Chem., 272, 5128-5132.
2. Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee Y-H, Ricote M, Glass CK, Brewer Jr HB and Gonzalez FJ. (2002). Mol. Cell. Biol., 22, 2607-2619.
3. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M and FitzGerald GA. (2003). J. Clin. Invest., 112, 945-955.
4. Berger J and Moller DE. (2002). Annu. Rev. Med., 53, 409-435.
5. Burstein HJ, Demetri GD, Mueller E, Sarraf P, Spiegelman BM and Winer EP. (2003). Breast Cancer Res. Treat., 79, 391-397.
6. Chan DC, Earle KA, Zhao TLM, Helfrich B, Zeng C, Baron A, Whitehead CM, Piazza G, Pamukcu R, Thompson WJ, Alila H, Nelson P and Bunn Jr PA. (2002). Clin. Cancer Res., 8, 904-912.
7. Chang T-H and Szabo E. (2000). Cancer Res., 60, 1129-1138.
8. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P and Evans RM. (2001). Nat. Med., 7, 48-52.
9. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, Wagner K-U and Hennighausen L. (2002). J. Biol. Chem., 277, 17830-17835.
10. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK and Brugge JS. (2002). Cell, 111, 29-40.
11. Debnath J, Muthuswamy SK and Brugge JS. (2003). Methods, 30, 256-268.
12. Demetri GD, Fletcher CD, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM and Singer S. (1999). Proc. Natl. Acad. Sci. USA, 96, 3951-3956.
13. Grommes C, Landreth GE and Heneka MT. (2004). Lancet Oncol., 5, 419-429.
14. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H and Grunert S. (2002a). J. Cell. Biol., 156, 299-313.
15. Janda E, Litos G, Grunert S, Downward J and Beug H. (2002b). Oncogene, 21, 5148-5159.
16. Jiang C, Ting AT and Seed B. (1998). Nature, 391, 82-86.
17. Kerr KM. (2001). J. Clin. Pathol., 54, 257-271.
18. Keshamouni VG, Reddy RC, Arenberg DA, Joel B, Thannickal VJ, Kalemkerian GP and Standiford TJ. (2004). Oncogene, 23, 100-108.
19. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ. (2004). Nat. Med., 10, 182-186.
20. Kinzler KW and Vogelstein B. (1996). Cell, 87, 159-170.
21. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC and Lehmann JM. (1995). Cell, 83, 813-819.
22. Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ and Fuchs CS. (2002). Cancer J., 8, 395-399.
23. Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, Geboes K, Briggs M, Heyman R and Auwerx J. (1998). Nat. Med., 4, 1053-1057.
24. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM and Kliewer SA. (1997). J. Biol. Chem., 272, 3406-3410.
25. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA. (1995). J. Biol. Chem., 270, 12953-12956.
26. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J and Haber DA. (2004). N. Engl. J. Med., 350, 2129-2139.
27. Malkinson AM. (1979). Toxicol. Appl. Pharmacol., 49, 551-560.
28. March TH, Marron-Terada PG and Belinsky SA. (2001). Vet. Pathol., 38, 483-490.
29. Marx N, Schonbeck U, Lazar MA, Libby P and Plutzky J. (1998). Circ. Res., 83, 1097-1103.
30. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S and Spiegelman BM. (1998). Mol. Cell, 1, 465-470.
31. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM and Kantoff PW. (2000). Proc. Natl. Acad. Sci. USA, 97, 10990-10995.
32. Nagy L, Tontonoz P, Alvarez JG, Chen H and Evans RM. (1998). Cell, 93, 229-240.
33. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE and Meyerson M. (2004). Science, 304, 1497-1500.
34. Roberts PE, Phillips DM and Mather JP. (1990). Am. J. Physiol., 259, L415-L425.
35. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M and Santoro MG. (2000). Nature, 403, 103-108.
36. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, Baird SM, Thomazy VA and Evans RM. (1998). Nat. Med., 4, 1058-1061.
37. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C and Spiegelman BM. (1998). Nat. Med., 4, 1046-1052.
38. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM and Eng C. (1999). Mol. Cell, 3, 799-804.
39. Sasaki H, Tanahashi M, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y and Fujii Y. (2002). Lung Cancer, 36, 71-76.
40. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G and Glass CK. (2000). Proc. Natl. Acad. Sci. USA, 97, 4844-4849.
41. Subbaramaiah K, Lin DT, Hart JC and Dannenberg AJ. (2001). J. Biol. Chem., 276, 12440-12448.
42. Takai Y, Sasaki T and Matozaki T. (2001). Physiol. Rev., 81, 153-208.
43. Theocharis S, Kanelli H, Politi E, Margeli A, Karkandaris C, Philippides T and Koutselinis A. (2002). Lung Cancer, 36, 249-255.
44. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P and Spiegelman BM. (1994). Nucleic Acids Res., 22, 5628-5634.
45. Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada T, Kohno M, Inoue K, Hla T and Kondo M. (2000). Biochem. Biophys. Res. Comm., 270, 400-405.
46. Whitehead CM, Earle KA, Fetter J, Xu S, Hartman T, Chan DC, Zhao TLM, Piazza G, Klein-Szanto AJP, Pamukcu R, Alila H, Bunn Jr PA and Thompson WJ. (2003). Mol. Cancer Ther., 2, 479-488.
47. Wick M, Hurteau G, Dessev C, Chan D, Geraci MW, Winn RA, Heasley LE and Nemenoff RA. (2002). Mol. Pharmacol., 62, 1207-1214.
48. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS and Merlino G. (2004). Nat. Med., 10, 175-181.
49. Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC and Reynolds SH. (2004). Oncogene, 23, 1405-1411.